MedReleaf (TSX:LEAF) announced it completed its first international export of cannabis oil.
As quoted in the press release:
The transaction is also noteworthy as the first ever import of medical cannabis oil to Brazil and serves as a demonstration of both the Company’s commitment to international growth and to establishing its position as the leading source of cannabis-based pharmaceutical products globally.
The export is being made to treat the symptoms of Sofia Langenbach, a child who carries the CDKL5 genetic syndrome – leading her to experience refractory epilepsy and severe seizures which for her, has only been alleviated by the use of medical cannabis. Her mother, Ms. Margarette Santos de Brito, currently president of APEPI (“Support for Research and Medical Cannabis Patients”), the first and largest Association of Cannabis patients in Brazil, previously won a landmark Brazilian court case to cultivate her own cannabis and has been one of the leading activists advocating for the legalization of medical cannabis in Brazil for many years.
“We have been working with Margarette Santos De Brito (president of Brazilian NGO APEPI), who has been a tireless, high-profile public champion of medical cannabis and whose daughter Sofia is in dire need of cannabis-based pharmaceutical products to manage her symptoms.” said Neil Closner, CEO of MedReleaf. “We are proud that Ms. Santos and ANVISA, the Brazilian Government’s National Health Surveillance Agency, have put their faith in MedReleaf.”
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).